This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prideaux, C. T.
Right arrow Articles by Hodgson, A. L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prideaux, C. T.
Right arrow Articles by Hodgson, A. L. M.

 Previous Article  |  Next Article 

Infection and Immunity, April 1999, p. 1962-1966, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Vaccination and Protection of Pigs against Pleuropneumonia with a Vaccine Strain of Actinobacillus pleuropneumoniae Produced by Site-Specific Mutagenesis of the ApxII Operon

C. T. Prideaux,* C. Lenghaus, J. Krywult, and A. L. M. Hodgson

Animal Health Laboratory, CSIRO Division of Animal Health, Geelong, Victoria 3120, Australia

Received 16 April 1998/Returned for modification 6 July 1998/Accepted 26 January 1999

The production of toxin (Apx)-neutralizing antibodies during infection plays a major role in the induction of protective immunity to Actinobacillus pleuropneumoniae reinfection. In the present study, the gene encoding the ApxII-activating protein, apxIIC, was insertionally inactivated on the chromosome of a serovar 7 strain, HS93. Expression of the structural toxin, ApxIIA, and of the two genes required for its secretion, apxIB and apxID, still occurs in this strain. The resulting mutant strain, HS93C- Ampr, was found to secrete the unactivated toxin. Pigs vaccinated with live HS93C- Ampr via the intranasal route were protected against a cross-serovar challenge with a virulent serovar 1 strain of A. pleuropneumoniae. This is the first reported vaccine strain of A. pleuropneumoniae which can be delivered live to pigs and offers cross-serovar protection against porcine pleuropneumonia.

* Corresponding author. CSIRO, Division of Animal Health, Animal Health Laboratory, Private Bag No. 24, Geelong, Victoria 3120, Australia. Phone: 61-3-5227 5000. Fax: 61-3-5227 5531. E-mail: Christopher.Prideaux{at}dah.csiro.au.

Infection and Immunity, April 1999, p. 1962-1966, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Maas, A., Jacobsen, I. D., Meens, J., Gerlach, G.-F. (2006). Use of an Actinobacillus pleuropneumoniae Multiple Mutant as a Vaccine That Allows Differentiation of Vaccinated and Infected Animals. Infect. Immun. 74: 4124-4132 [Abstract] [Full Text]  
  • Baltes, N., Tonpitak, W., Gerlach, G.-F., Hennig-Pauka, I., Hoffmann-Moujahid, A., Ganter, M., Rothkotter, H.-J. (2001). Actinobacillus pleuropneumoniae Iron Transport and Urease Activity: Effects on Bacterial Virulence and Host Immune Response. Infect. Immun. 69: 472-478 [Abstract] [Full Text]  
  • Guerrero-Barrera, A. L., de la Garza, M., Mondragon, R., Garcia-Cuellar, C., Segura-Nieto, M. (1999). Actin-related proteins in Actinobacillus pleuropneumoniae and their interactions with actin-binding proteins. Microbiology 145: 3235-3244 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»